Presentation slides and video from the 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Toxicity Management - Part 2 were presented virtually on June 27, 2023.
Program Organizers
Target Audience
The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.
Program Learning Objectives
Identify appropriate clinical management of common immune-related adverse events resulting from cancer immunotherapy treatments, including immune checkpoint inhibitors and cell therapies.
Outline best practices for multidisciplinary management of patients receiving cancer immunotherapy treatment.
Describe management approaches for difficult or refractory immune-related adverse events.
You can view the program details here.
Please note on-demand recordings are not available for continuing education credits.
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Toxicity Management - Part 2; Date: June 27, 202301:00:54
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Toxicity Management - Part 2; Presenter: Ala Abudayyeh, MD; Date: June 27, 202300:16:12
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Toxicity Management - Part 2; Presenter: Nagham Al-Zubidi, MD; Date: June 27, 202300:10:39
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Toxicity Management - Part 2; Presenter: Marisa McGinley, DO; Date: June 27, 202300:17:57
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Toxicity Management - Part 2; Date: June 27, 202300:10:09
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Toxicity Management - Part 2; Presenter: Anusha Thomas, MD; Date: June 27, 202300:13:53
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Toxicity Management - Part 2; Presenter: Hao Chi (Joseph) Zhang, MD; Date: June 27, 202300:13:28
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Toxicity Management - Part 2; Presenter: Yinghong (Mimi) Wang, MD, PhD, MSc; Date: June 27, 202300:22:58
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Toxicity Management - Part 2; Presenter: Krista Rubin, MS, FNP-BC; Date: June 27, 202300:26:10
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Toxicity Management - Part 2; Presenter: Pauline Funchain, MD; Date: June 27, 202300:21:39